The Challenges of ST-Elevation Myocardial Infarction in COVID-19 Patients
By July 2021, the United States had over 34.4 million confirmed COVID-19 cases. Various cardiovascular manifestations of COVID-19 have been reported including ST-elevation myocardial infarction (STEMI), and there is concern that SARS-CoV-2 may be associated with a higher thrombus burden. We performe...
Saved in:
Main Authors: | Ju Young Bae, Khalil Ian Hussein, Christopher John Howes, John Francis Setaro |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2021/9915650 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cocaine and COVID-19 in ST-Elevation Myocardial Infarction
by: Florian Appenzeller, et al.
Published: (2022-01-01) -
ST Elevation Myocardial Infarction in Patients with COVID-19: Case Series
by: Sofia Lakhdar, et al.
Published: (2022-03-01) -
ST-segment elevation myocardial infarction hospitalisations remain unchanged during COVID-19
by: Chieh Yang Koo, et al.
Published: (2022-11-01) -
Examining the Specificity of Smartphone ECG Devices in Decision-Making for ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction
by: Sahil mahajan, et al.
Published: (2025-01-01) -
ST-Elevation Myocardial Infarction in the Presence of Septic Shock
by: Leah Ishmael, et al.
Published: (2020-01-01)